Search research articles
Contact Us
Filters
Showing results (1-10 of 13) with videos related to
Page
of 2
Sort By:
Oncology (Williston Park, N.Y.)
|
March 17, 2001
Gemcitabine plus cisplatin in breast cancer
R A Nagourney
Gynecologic Oncology
|
January 6, 2000
Correlation between extreme drug resistance assay and response to primary paclitaxel and cisplatin in patients with epithelial ovarian cancer
R A Nagourney
Journal of the National Cancer Institute
|
October 2, 1991
Multidrug resistance in acute myeloid leukemia
R A Nagourney
Cancer Research
|
January 1, 1978
A comparison of the biological and biochemical properties of 1-(4-amino-2-methylpyrimidin-5-yl)methyl-3-(2-chloroethyl)-3-nitrosourea and 2-[3-(2-chloroethyl)-3-nitrosoureido]-D-glucopyranose
R A Nagourney, P Fox, P S Schein
Annals of Internal Medicine
|
June 1, 1985
Carcinoid carcinomatous meningitis
R A Nagourney, R Hedaya, M Linnoila, et al.
Cancer Chemotherapy and Pharmacology
|
January 1, 1990
Enhancement of anthracycline and alkylator cytotoxicity by ethacrynic acid in primary cultures of human tissues
R A Nagourney, J C Messenger, D H Kern, et al.
Progress in Clinical and Biological Research
|
January 1, 1988
Non-clonogenic, in vitro assays for predicting sensitivity to cancer chemotherapy
L M Weisenthal, Y Z Su, T E Duarte, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 1, 2000
Gemcitabine plus cisplatin repeating doublet therapy in previously treated, relapsed breast cancer patients
R A Nagourney, J S Link, J B Blitzer, et al.
British Journal of Cancer
|
October 30, 2003
Ex vivo analysis of topotecan: advancing the application of laboratory-based clinical therapeutics
R A Nagourney, B L Sommers, S M Harper, et al.
International Journal of Radiation Biology
|
November 1, 1989
Radiation response of cells from human tumor biopsies as assessed by a dye exclusion technique: a possible predictive assay
W Kurohara, M Colman, R A Nagourney, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 13) with videos related to
Sort By:
Page
of 2
Oncology (Williston Park, N.Y.)
|
March 17, 2001
Gemcitabine plus cisplatin in breast cancer
R A Nagourney
Gynecologic Oncology
|
January 6, 2000
Correlation between extreme drug resistance assay and response to primary paclitaxel and cisplatin in patients with epithelial ovarian cancer
R A Nagourney
Journal of the National Cancer Institute
|
October 2, 1991
Multidrug resistance in acute myeloid leukemia
R A Nagourney
Cancer Research
|
January 1, 1978
A comparison of the biological and biochemical properties of 1-(4-amino-2-methylpyrimidin-5-yl)methyl-3-(2-chloroethyl)-3-nitrosourea and 2-[3-(2-chloroethyl)-3-nitrosoureido]-D-glucopyranose
R A Nagourney, P Fox, P S Schein
Annals of Internal Medicine
|
June 1, 1985
Carcinoid carcinomatous meningitis
R A Nagourney, R Hedaya, M Linnoila, et al.
Cancer Chemotherapy and Pharmacology
|
January 1, 1990
Enhancement of anthracycline and alkylator cytotoxicity by ethacrynic acid in primary cultures of human tissues
R A Nagourney, J C Messenger, D H Kern, et al.
Progress in Clinical and Biological Research
|
January 1, 1988
Non-clonogenic, in vitro assays for predicting sensitivity to cancer chemotherapy
L M Weisenthal, Y Z Su, T E Duarte, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 1, 2000
Gemcitabine plus cisplatin repeating doublet therapy in previously treated, relapsed breast cancer patients
R A Nagourney, J S Link, J B Blitzer, et al.
British Journal of Cancer
|
October 30, 2003
Ex vivo analysis of topotecan: advancing the application of laboratory-based clinical therapeutics
R A Nagourney, B L Sommers, S M Harper, et al.
International Journal of Radiation Biology
|
November 1, 1989
Radiation response of cells from human tumor biopsies as assessed by a dye exclusion technique: a possible predictive assay
W Kurohara, M Colman, R A Nagourney, et al.
Page
of 2